Esperion Therapeutics | ESPR - درآمد حاصل از بهره





درآمد حاصل از بهره تغییر دادن تاریخ
AbbVie USD 72M 10M 2025-09
Alnylam Pharmaceuticals USD 28.68M 1.19M 2025-09
Amarin USD 3.37M 3.37M 2024-12
Biogen USD 31.6M 700K 2025-09
BioMarin Pharmaceutical USD 17.85M 973K 2025-09
CSL USD 18M 1000K 2024-12
Cytokinetics USD 10.25M 2.75M 2025-09
Daiichi Sankyo JPY 9.96B 230M 2024-03
Eli Lilly USD 65M 25M 2025-09
Esperion Therapeutics USD -0.15 0.18 2024-09
Geron USD 4.26M 392K 2025-09
Heron Therapeutics USD 433K 277K 2021-12
Ionis Pharmaceuticals USD -0.66 0.29 2024-12
Merck USD 96M 27M 2025-09
Moderna USD 73M 8M 2025-09
Nektar Therapeutics USD -0.18 0.07 2024-09
Pfizer USD 0.62 156M 2025-09
Puma Biotechnology USD 0.41 0.5 2024-09
Regeneron Pharmaceuticals USD 175.1M 300K 2025-09
Sanofi EUR 114M 38M 2025-09
Sarepta Therapeutics USD 8.38M 1.24M 2025-09
United Therapeutics USD 46.4M 4.9M 2025-09